Aspirin study raises hopes for dementia prevention

Original article by Kathy Evans
The Age – Page: 11 : 5-Jan-15

The US National Institutes of Health agency is funding new research by Monash University’s School of Public Health & Preventive Medicine in Melbourne. The aim is to establish whether aspirin’s anti-inflammatory properties can be used to prevent deafness, blindness and dementia in older patients. The "ASPirin in Reducing Events in the Elderly" (ASPREE) project also involves the Berman Centre for Outcomes & Clinical Research in Minneapolis, and will have 19,000-plus test subjects

CORPORATES
MONASH UNIVERSITY, UNITED STATES. DEPT OF HEALTH AND HUMAN SERVICES. NATIONAL INSTITUTES OF HEALTH, MINNEAPOLIS MEDICAL RESEARCH FOUNDATION. BERMAN CENTER FOR OUTCOMES AND CLINICAL RESEARCH